Allakos (ALLK) Company Cash Funds

ALLK (Allakos Inc.) - company brandmark

Allakos Inc. management is openly reporting test results in an effort to expand its development portfolio. The change in cash balance on the GURU.Markets chart demonstrates liquidity, while the 0.06 metric indicates the status of funds reserved for R&D. Business success relies on therapy safety and the results of GI antibody trials in the complete absence of current sales.

Company Cash Reserve: allakos.com (ALLK) for 07/04/2022 - 05/24/2025

Financial and market metric breakdowns for Allakos Inc. (ALLK)

Basic company analysis:ALLK allakos.com
Product sample of Allakos Therapeutics

This indicator measures the volume of liquid assets on the balance sheet, determining the degree of the business's financial autonomy. An increase in this metric reduces reliance on borrowings, although an excess of funds may indicate low capital efficiency. By analyzing the company's cash history, an investor assesses the margin of safety for operational activities. For Allakos Inc. (ALLK), this resource is critically important for financing costly clinical trials. Sufficient capital allows the company to retain leading immunologists through extensive research budgets.

Who Allakos Inc. competes with

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|CLDX: Company Cash Balance|Company Cash Funds Aurinia Pharmaceuticals Inc. (AUPH)|Company Cash Funds BCRX (BioCryst Pharmaceuticals Inc)|Company Cash Volume VERA (Vera Corp)|Company Total Cash Amount DNTH (Dianthus Therapeutics)|PHVS - Company Cash Funds|ABCL: Company Cash Funds|TRML: Company Cash Volume|Company Cash on Hand Precigen, Inc.|Company Cash on Hand PHAR|Nektar Therapeutics - Company Total Cash Volume|Company Cash Funds Upstream Bio Corp (UPB)|Company Cash on Hand Zenas Biopharma ZBIO|Company Cash Funds Immunome Bio IMNM|GOSS: Company Cash and Cash Equivalents|kalvista.com - Company Cash Volume|SEPN (septerna.com) - Company Cash and Cash Equivalents|PVLA (Pieris Pharmaceuticals) - Company Cash on Hand|Savara - Company Cash Balance|RIGL (Rigel Corp) - Company Cash Volume|Company Cash Volume AnaptysBio Corp|Company Cash Funds astriatx.com (ATXS)|Company Cash on Hand enGene ENGN|Company Cash Funds RAPT Therapeutics, Inc. RAPT|JBIO - Company Cash on Hand|Aclaris Therapeutics Inc. - Company Cash Volume|KYTX - Company Cash Volume|TLSA (Tiziana Life Sciences PLC) - Company Cash on Hand|cabalettabio.com (CABA) - Company Cash Volume|Company Cash Funds Ventyx Biosciences|THTX (Theratechnologies) - Company Total Cash Amount|Company Cash on Hand AVTX (Avalo Therapeutics Inc.)|Company Cash Funds ELDN (Eledon)|Company Cash Volume AGEN (Agenus, Inc)|Company Liquid Assets climbbio.com (CLYM)|zurabio.com - Company Cash Volume|ATYR - Company Cash Volume|ADAG: Company Cash Volume|Ikena Oncology, Inc. (IMA) - Company Cash Volume|STTK (Shattuck Therapeutics) - Company Cash Volume|Company Cash Reserve equilliumbio.com EQ|Company Cash Volume CNTB|IMUX - Company Cash Reserve|Company Cash Funds Atara Biotherapeutics ATRA|Company Liquid Assets InflaRx N.V. (IFRX)|XFOR: Company Cash on Hand|adicetbio.com (ACET) - Company Cash on Hand|CELU: Company Cash Volume|Company Cash Reserve INmune Bio (INMB)|Company Cash Funds Barinthus Bio|Company Cash and Cash Equivalents KZR (Kezar Life Sciences, Inc)|Company Cash on Hand SABS (SAB Biotherapeutics Inc)|Akari Therapeutics - Company Cash and Cash Equivalents|Enlivex Therapeutics Ltd - Company Cash on Hand|Company Cash Balance QTTB|GOVX - Company Cash Funds|Company Cash Reserve Edesa|IBIO: Company Cash Volume|Company Cash Reserve Carisma Therapeutics Inc (CARM)|Company Cash Funds XTL Biopharmaceuticals, Ltd.|Company Cash Funds BOLT|Company Cash on Hand HCWB (HCW Biologics, Inc.)|Company Total Cash Amount APVO|AIM ImmunoTech - Company Cash on Hand|Company Cash Balance ADTX|GRI - Company Cash Funds|XRTX (XORTX Therapeutics Inc) - Company Cash and Cash Equivalents|HIND: Company Cash Volume|REVB (Revelation Bio) - Company Cash Funds|Company Cash Funds Indaptus|Scinai Immunotherapeutics (SCNI) - Company Liquid Assets|Company Cash Volume CALI|Company Cash on Hand Affimed NV AFMD|Company Cash Funds HOOKIPA Pharma, Inc. HOOK|Company Liquid Assets IGM Bio (IGMS)|iTeos Pharma - Company Cash Volume|Company Liquid Assets oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Company Cash Funds|Company Cash and Cash Equivalents THRD